Home > Quotes > ABIO
ABIO

ARCA biopharma, Inc. Stock Quote & Summary Data

$0.77
*  
0.01
1.32%
Get ABIO Alerts
*Delayed - data as of May 22, 2015  -  Find a broker to begin trading ABIO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Best Bid/Ask "Best Bid" is the highest price currently being offered for a block of stock.
"Best Ask" is the lowest price currently being asked for a block of stock.
N/A / N/A
1 Year Target 3.375
Today's High /Low "Today's High" The highest sales price the stock has achieved during the regular trading hours, the intra-day high.
"Today's Low" The lowest sales price the stock has fallen to during the regular trading hours, the intra-day low.
 / 
Share Volume "Share Volume" is the number of shares of the stock traded on the listing exchange during current trading hours. It does not include after hours volume.
50 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 382,863
Previous Close "Previous Close" is the previous trading day's last reported trade price during official trading hours. $ 0.76
52 Week High/Low "52 Week High" is the highest sales price the stock has achieved during the regular trading hours during the most recent 52 week period.
"52 Week Low" is the lowest sales price the stock has fallen to during the regular trading hours during the most recent 52 week period.
$ 1.65 / $ 0.645
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 16,322,776
Annualized dividend N/A
Ex Dividend Date N/A
Dividend Payment Date N/A
Current Yield Indicated yield represents annual dividends divided by current stock price. 0 %
Beta "Beta" is a volatility measurement of a stock mutual fund or ETF versus a comparable benchmark like the S&P 500 stock index. A stock fund or ETF with a higher beta than the S&P 500 will rise or fall to a greater degree. In contrast, a stock fund or ETF with a low beta will rise or fall less. -0.58
NASDAQ Official Open Price NASDAQ Official Opening Price: This process identifies the NASDAQ-specific opening prices for NASDAQ-listed issues. $ 0.7516
Date of Open Price "Date of Open Price" This field refers to the date the NASDAQ Official Open Price was disseminated for a given stock. It is possible that the date will not be from the current trading day; this indicates that the stock didn't trade on NASDAQ during the current trading day. The NASDAQ Official Open Price is updated only when the stock is traded on NASDAQ. May 22, 2015
NASDAQ Official Close Price "NASDAQ Official Closing Price (NOCP)" is a process for identifying the NASDAQ market-specific closing price for NASDAQ-listed issues. $ 0.76
Date of Close Price This field refers to the date the NOCP was disseminated for a given stock. It is possible that the date will not be from the prior day; this indicates that the stock didn't trade on NASDAQ on the prior day. The NOCP is updated only when the stock is traded on NASDAQ. May 22, 2015
Community Sentiment

Intraday Chart

Company Description (as filed with the SEC)

ARCA biopharma, Inc. (the "Company" or "ARCA"), a Delaware corporation, is headquartered in Broomfield, Colorado and is principally focused on developing genetically-targeted therapies for heart failure and other cardiovascular diseases. The Company's lead product candidate is Gencaro TM (bucindolol hydrochloride), a pharmacologically unique beta-blocker and mild vasodilator for chronic heart failure, or HF. Gencaro was the subject of a Phase 3 heart failure mortality trial involving more than 2,700 patients and was unique in gathering DNA data on over 1,000 of its participants. The Company has licensed exclusive, worldwide rights to Gencaro. In September 2008, the U.S. Food and Drug Administration ("FDA") accepted for filing the Company’s New Drug Application ("NDA") for Gencaro. On May 29, 2009, the FDA issued a Complete Response Letter to the Company which stated that the FDA could not approve the Gencaro NDA in its current form and specified additional actions and information required by the FDA for approval of the NDA.  ... More ...  

Risk Grade

Where does ABIO fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?